All Else Equal: Making Better Decisions
Ep18 “Investigating Implausible Theories” with John Ioannidis
18 Jan 2023
In science, we often hear about new discoveries or theories that could change our way of thinking. In the business world, a start-up might promise a revolution in a specific industry, if it can get the right investments. So, when is it worth believing or betting on one of these new theories, and when is it a waste of time? In this episode of All Else Equal, Jules and Jonathan discuss how we can all use the principle of Occam’s Razor (the idea that the simplest theory is often the correct one) in many different areas of our life.Helping them explain the real world practice of this is John Ioannidis, a professor of Medicine and Epidemiology at Stanford University. John was the first academic to question the practices of Theranos, the company co-founded by Elizabeth Holmes that claimed it would change medicine with its new method of testing blood. He criticized the lack of peer reviewed research of the company’s methods, while at the same time investors were making it a billion dollar company. John tells Jules and Jonathan about this experience, as well as how Occam’s Razor comes into play with a lot of scientific research. Submit your questions to the show here: https://bit.ly/AllElseEqualFind All Else Equal on the web: https://www.gsb.stanford.edu/business-podcasts/all-else-equal-making-better-decisionsAll Else Equal: Making Better Decisions Podcast is a production of Stanford Graduate School of Business and is produced by University FM.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
No persons identified in this episode.
This episode hasn't been transcribed yet
Help us prioritize this episode for transcription by upvoting it.
Popular episodes get transcribed faster
Other recent transcribed episodes
Transcribed and ready to explore now
SpaceX Said to Pursue 2026 IPO
10 Dec 2025
Bloomberg Tech
Don’t Call It a Comeback
10 Dec 2025
Motley Fool Money
Japan Claims AGI, Pentagon Adopts Gemini, and MIT Designs New Medicines
10 Dec 2025
The Daily AI Show
Eric Larsen on the emergence and potential of AI in healthcare
10 Dec 2025
McKinsey on Healthcare
What it will take for AI to scale (energy, compute, talent)
10 Dec 2025
Azeem Azhar's Exponential View
Reducing Burnout and Boosting Revenue in ASCs
10 Dec 2025
Becker’s Healthcare -- Spine and Orthopedic Podcast